Short link to this page http://wp.me/pfSi7-1Vb
Gardasil Destroys Girl’s Ovaries: Research on Ovaries Never Considered
The BMJ has published the case report of a healthy 16-year-old Australian girl whose womanhood appears to have been stolen by Gardasil vaccinations. She has been thrust into full-fledged menopause, her ovaries irrevocably shut down, before becoming a woman.
The authors, Deirdre Therese Little and Harvey Rodrick Grenville Ward1, draw direct attention to the fact that, though the girl has been thoroughly examined and tested, there is no known explanation other than the series of three Gardasil vaccinations she had.
[1] Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination, BMJ Reports 2012, Deirdre Therese Little, Harvey Rodrick Grenville Ward, doi:10.1136/bcr-2012-006879
CHS notes as is reported in the nsnbc.com report, the manufacturer provided information to the Australian Therapeutic Goods Administration (TGA) on tests carried out on male rat testes from litters of newborn rats, but not for female rat ovaries. There is no explanation why the manufacturer omitted this information. There are likely to be as many female newborns as male in any litter and as the vaccine was to be given to women and girls this missing information is significant.
Additionally, the paper’s authors acknowledge that in 90% of cases the cause is unknown. The authors draw attention to the fact that whilst it is a rare condition to occur in a teenage girl it is more unusual in a well teenage individual. Whilst the predominant causes are different in the adolescent the cause is not proven to be the vaccine. However, the number of women with POF is increasing.
Re Posted by CHS. Original Post: The Liberty Beacon™ Staff Published July 22, 2013, filed under HEALTH
Read on for more: Gardasil Destroys Girl’s Ovaries: Research on Ovaries Never Considered
________________________________
As Gardasil is the same vaccine given universally to all British 12 year-old schoolgirls since Sept 2012 and to US women and girls CHS is also reposting here the following world exclusive report published only two days ago. [Added July 30 @ 0511GMT / 29 July @2211PDT]
WORLD EXCLUSIVE – UK Drug Safety Agency Falsified Vaccine Safety Data For 6 Million – Millions of Children At Serious Risk
Posted on July 28, 2013 by ChildHealthSafety
Short link to this page: http://wp.me/pfSi7-1UC
This world exclusive report by CHS follows the decision by health authorities in Japan to withdraw their recommendation for human papilloma virus [HPV] vaccines because of high levels of serious adverse reactions in Japanese women and girls. Japanese girls will still be able to be vaccinated at no charge, but from now on they will be informed by healthcare providers that the health ministry does not recommend the vaccines.
Cervarix and Gardasil HPV vaccines were found to cause substantially higher rates of adverse reactions than other vaccines: Cervix vaccine issues trigger health notice Japan Times Jun 15, 2013 National Kyodo.
One report claims the rate of serious adverse reactions which Japanese women experienced after Cervarix injections are 52 times the rate of those reported after annual influenza vaccines: Urgent Request from Japan: Help Stop HPV Vaccinations July 27, 2013 By Norma Erickson SaneVax, Inc.
The UK media fail to report this kind of news affecting millions of British school children and families despite affecting their own families and networks of relatives in the UK. Journalism is a dying profession. So don’t buy newspapers or believe TV news reports. The UK’s BBC has become the British Government’s press office.
British Parents Not Told Their Children Are Not At Risk of Cervical Cancer
The targeted vaccination group of 12-year-old British schoolgirls are at no risk of contracting cervical cancer. Cervical cancer is an extremely rare disease. The risk is normally zero up to age 20. The risk of serious adverse reactions from the vaccine is therefore infinitely higher. In the UK the disease is so rare there are just 3 deaths in every 100,000 women of all ages as figures from Cancer Research UK show. What is worse is that by the time there is any risk for these schoolgirls any effect from the vaccine [if there ever was one] would have worn off yet these young women may then think they are protected and fail to undergo routine screening when they will still need it regardless of the vaccine.
By the time there is any risk of mortality for these 12 year-old schoolgirls it is extremely low. The risk of death from cervical cancer in the age range 20-24 is 3 in every million women of that age range. The disease does not normally affect schoolgirls. The highest number of deaths occur in women in their late seventies.
How UK Health Officials Tampered With the Adverse Reaction Reporting Systems
In the UK the Medicines and Healthcare Products Regulatory Agency [MHRA] first interference was to encourage health professional not to report adverse reactions. This was done in formal advice issued in the name of Chief Executive Professor Sir Kent Woods telling health professionals that reactions can be “psychogenic” – or in simpler terms a figment of 12 year old schoolgirls’ imaginations and nothing to do with the vaccines [see more below for full details].
Next the data from over 6000 reports of suspected adverse reactions was systematically altered resulting in the MHRA declaring the vaccine safe when it was not.
The third thing the MHRA staff did was to fix the final figures to make the rate of adverse reactions appear lower by substituting the number of doses given for the number of children receiving the vaccine. Tampering with statistics by basing rates of adverse reactions on doses given reduced the numbers of adverse reactions per child by three times. This is because each child was to receive three doses of the vaccine. So whilst 6 million doses may have been given that represented only around one third of that figure in children receiving the vaccine – resulting in the rates of adverse reactions reported being calculated as 300% lower than they were per child.
In other words if all children received all three doses then the crucial figure was not the number of doses but the number of children who suffered reactions compared to the total number of children.
The MHRA was headed at the time by Chairman Professor Alasdair Breckenridge [retired December 2012] and Professor Sir Kent Woods [MHRA Chief Executive but shortly expected to retire after 10 years service].
Questions For Heads Of UK Drug Regulatory Agency – MHRA
The first question for Professors Breckenridge and Woods is – if Japanese women suffered adverse reactions at a rate 52 times higher for GSK’s Cervarix vaccine than for flu vaccine how can possible adverse reactions just be figments of childrens’ imagination and so are not to be reported by medical professionals? [“psychogenic” was how Woods put it more formally – see his official advice to medical professionals – more below].
Clearly, that cannot be the case. Not only that but Woods and Breckenridge cannot claim to be ignorant of those facts. They must know that is the position. Nearly half of all reports included what the MHRA categorised as “psychogenic” symptoms which the MHRA say are “all in the mind” and could not therefore be caused by the vaccine. A full list in a spreadsheet to enable further sorting and analysis can be downloaded here: 130728 Single list of all Cervarix Yellow Card Reports or browsed at the end of this article.
You can also download the MHRA’s own published .pdf analyses listing the symptoms reported broken up into these five groups. These are the reports used to declare the vaccine safe:
Here are just a few examples of MHRA’s alleged “all in the mind” “psychogenic” reactions by “hysterical schoolgirls”:
- convulsions [which are serious reactions with risks of serious brain injury];
- grand mal convulsions;
- deafness
- circulatory collapse;
- acquired colour blindness;
- head banging;
- foaming at mouth;
- transient blindness;
- transient deafness;
The next question is: who instructed staff of the UK’s Medicines and Healthcare Products Regulatory Agency [MHRA] systematically to tamper with the reporting systems and with data in reports of adverse reactions by medical professionals to Cervarix HPV vaccines given to millions British Schoolgirls from December 2008 to July 2012?
And the next question is who instructed that none of the adverse reaction reports should be followed-up and conditions of the children investigated? There is little point having drug safety monitoring if the data obtained from it is ignored. The MHRA hid the conditions in those cases which were reported.
Official Excuses for Withdrawal of GSK’s Cervarix HPV Vaccine Do Not Stand Up
In 2012 GSK’s Cervarix HPV vaccine was replaced by Merck’s Gardasil HPV vaccine. At the time this was claimed to be a result of competitive tendering. However it is a requirement that the Department of Health is required to ensure vaccine supply is not from a sole source. This requirement was made following criticism in the English Parliament and by the UK National Audit Office over problems caused previously by the failure of a sole source of supply of a different vaccine.
Professor Sir Kent Woods Instructs Medical Professionals Not To Report Adverse Reactions.
In advice dated 2nd September 2008 issued by the UK MHRA in Professor Kent Woods name Professor Woods primed health professionals to expect the most common adverse reactions would be “psychogenic”. Professor Woods then advised medical professionals not to report an adverse reaction if it “may” be psychogenic.
“Psychogenic” means that the symptom of the adverse reaction is to be treated as “all in the minds” of the British schoolgirls receiving GSK’s Cervarix vaccine – that is: the result of emotional or mental stress from the administration of the vaccine.
In other words – and feminists please take note – the male dominated MHRA was telling medical professionals to dismiss adverse reactions in schoolgirls because women are prone to that sort of thing – you know – women are silly, emotional and prone to hysteria and mass hysteria.
This advice was not only counterproductive but unscientific and improper from a drug safety perspective. Professors Woods and Breckenridge must know that.
Adverse reactions to all pharmaceuticals are heavily under-reported. Because of that medical professionals are constantly and generally encouraged to file adverse reaction reports to improve drug safety monitoring. Professor Woods’ advice was encouraging them not to.
An adverse reaction reporting system relies on the spectrum of adverse events to be reported so that it is possible to identify the “signal” of a previously unidentified adverse drug reaction against the background of known adverse reactions and reports.
By encouraging medical professionals to expect and then not to report suspected “psychogenic” reactions would result in reactions which were not psychogenic being identified as such and which would then not be reported following Professor Kent Woods’ advice. This would also make drug safety monitoring much less effective because if there were truly any “psychogenic” reactions, then subsequent analyses of the data could assist to identify which were likely to have been and which were not so likely or were not. But the less data one has makes the task more difficult.
MHRA Systematically Tampered with 6000 reports of Adverse Reactions To Declare The Vaccine Safe
From April 2008 up to 31st July 2012, the MHRA received a total of 6213 reports of suspected adverse reactions documenting 14,300 symptoms or 2 1/2 symptoms per report. Nurses contributed more than two-thirds of all reports. Over 6 million doses of the vaccine were administered.
The way the reports of suspected adverse reactions to GSK’s Cervarix vaccine were tampered with was to ensure the underlying conditions indicated by the reported symptoms could not be identified. In addition, no clinical follow-up was carried out on any Cervarix Yellow Card report of a suspected adverse reaction.
To diagnose an individual it is essential to consider all symptoms suffered by that individual and carry out a clinical assessment on a case-by-case basis. For example, how do you know if you might have flu? If you have fever, cough, headache, aching muscles and tiredness then you may have flu.
What the MHRA did was to carry out a paper analysis of the Yellow Card reports. They separated out the symptoms reported for each individual so that it would be impossible for anyone to identify the underlying conditions each individual suffered. SOURCE: MHRA 29 July 2010 “Suspected Adverse Reaction Analysis”
Here are the 5 categories each symptom was separated into:
A. Injection-site reactions
B. Allergic reactions
C. ‘Psychogenic’ events
D. ‘Other recognised’ reactions
E. not currently recognised
So if we consider by analogy a disease most people know about, flu, if this approach was applied to infectious disease reports each symptom would be split up and put into one or more of these categories. As the symptoms are no longer linked together it is impossible to say whether anyone was suffering from ‘flu or any other disease. There would be no way of telling.
Thus, the MHRA set about hiding the numbers and types of suspected ADRs suffered by British schoolchildren. This was not a conspiracy but fact – that is what the MHRA did.
If this approach were adopted to reporting infectious diseases generally the public could have no idea which diseases are present in the population at any time. There can be numerous infections diseases circulating simultaneously.
For example, a symptom of encephalitis is headache – in the period Sept 08 to 29 July 2010 information from MHRA recorded that in 4703 Yellow Card reports there were 848 reports which included headache as one of the reported symptoms and which might therefore be of encephalitis. A “quick and dirty” analysis of the MHRA data issued at that time shows that of just 5 of the 32 symptoms of encephalitis at least 2300 reports include at least one symptom of encephalitis.
But this is what the MHRA said having carried out no clinical investigation or analysis of any of the Yellow Card reports:-
The four cases of encephalitis reported so far, amongst the number of girls immunised, do not exceed the numbers normally expected in the absence of vaccination. There is therefore no suggestion at present that the vaccine can cause encephalitis.”
SOURCE: MHRA 29 July 2010 “Suspected Adverse Reaction Analysis“
This shows
- MHRA only recorded a report as suspected encephalitis if those specific words appear on the Yellow Card report
- and confirms MHRA did not consider what underlying conditions are indicated by the symptoms reported on the Yellow Cards
Most reports were by school nurses who are likely only to report the symptoms and not diagnose underlying conditions.
School Head Teachers & Governors
It is obvious from these figures that UK parents are obliged under their Children Act 1989 legal duties to refuse consent. This also puts head teachers and school governors in a remarkable position for putting children at risk by allowing these vaccination programmes to take place on school premises. Under English law they stand legally in “loco parentis” – in the place of the parents whilst children are under their care in school.
School Nurses & Other Medical Professionals.
Obviously medical practitioners bear a heavy duty of disclosure to obtain informed consent but they are not fulfilling it. Additionally, it is obvious that anyone proposing to have this vaccine needs to be screened for 1) pre-existing medical conditions putting them at risk and 2) risk of adverse reactions based on prior clinical history. That is not being done.
Properly informed consent is not being obtained – which legally can give rise to claims for “battery” – not simply negligence and easier to prove.
Parents are being told their 13-year-old girls may be given the vaccine even if the parents refuse consent. Girls of this age might be subject to pressure to persuade them even if parents have refused consent. There are reasons why this may not be lawful under “Gillick competence”.
ANNEX I
LIST OF MHRA REPORTED SYMPTOMS OF ADVERSE REACTIONS TO GSK’S CERVARIX HPV VACCINE – Source MHRA “Suspected Adverse Reaction Analysis” 29th July 2010
[Also downloadable as a spreadsheet from here 130728 Single list of all Cervarix Yellow Card Reports]
| System Organ Class | Category A to E | Reported event (Preferred Term) |
Number of cases |
| A. Injection-site reactions | Pain in extremity 485 |
485 |
|
| A. Injection-site reactions | Injection site swelling 113 |
113 |
|
| A. Injection-site reactions | Oedema peripheral 109 |
109 |
|
| A. Injection-site reactions | Limb discomfort 106 |
106 |
|
| A. Injection-site reactions | Hypoaesthesia 105 |
105 |
|
| A. Injection-site reactions | Injection site erythema 85 |
85 |
|
| A. Injection-site reactions | Injection site pain 81 |
81 |
|
| A. Injection-site reactions | Erythema 45 |
45 |
|
| A. Injection-site reactions | Paraesthesia 37 |
37 |
|
| A. Injection-site reactions | Skin discolouration 33 |
33 |
|
| A. Injection-site reactions | Injection site rash 32 |
32 |
|
| A. Injection-site reactions | Injection site mass 29 |
29 |
|
| A. Injection-site reactions | Injection site reaction 26 |
26 |
|
| A. Injection-site reactions | Pain 23 |
23 |
|
| A. Injection-site reactions | Contusion 21 |
21 |
|
| A. Injection-site reactions | Musculoskeletal stiffness 21 |
21 |
|
| A. Injection-site reactions | Peripheral coldness 20 |
20 |
|
| A. Injection-site reactions | Local reaction 19 |
19 |
|
| A. Injection-site reactions | Injection site inflammation 18 |
18 |
|
| A. Injection-site reactions | Injection site warmth 18 |
18 |
|
| A. Injection-site reactions | Pain in extremity 16 |
16 |
|
| A. Injection-site reactions | Local swelling 15 |
15 |
|
| A. Injection-site reactions | Sensation of heaviness 15 |
15 |
|
| A. Injection-site reactions | Injection site haematoma 12 |
12 |
|
| A. Injection-site reactions | Injection site pruritus 11 |
11 |
|
| A. Injection-site reactions | Rash macular 10 |
10 |
|
| A. Injection-site reactions | Oedema peripheral 9 |
9 |
|
| A. Injection-site reactions | Feeling cold 8 |
8 |
|
| A. Injection-site reactions | Injection site induration 8 |
8 |
|
| A. Injection-site reactions | Injection site nodule 8 |
8 |
|
| A. Injection-site reactions | Livedo reticularis 8 |
8 |
|
| A. Injection-site reactions | Swelling 8 |
8 |
|
| A. Injection-site reactions | Injection site anaesthesia 6 |
6 |
|
| A. Injection-site reactions | Injection site swelling 6 |
6 |
|
| A. Injection-site reactions | Muscular weakness 6 |
6 |
|
| A. Injection-site reactions | Myalgia 6 |
6 |
|
| A. Injection-site reactions | Neck pain 6 |
6 |
|
| A. Injection-site reactions | Pain 6 |
6 |
|
| A. Injection-site reactions | Rash 6 |
6 |
|
| A. Injection-site reactions | Erythema 5 |
5 |
|
| A. Injection-site reactions | Feeling hot 5 |
5 |
|
| A. Injection-site reactions | Injection site erythema 5 |
5 |
|
| A. Injection-site reactions | Pruritus 5 |
5 |
|
| A. Injection-site reactions | Cyanosis 4 |
4 |
|
| A. Injection-site reactions | Feeling abnormal 4 |
4 |
|
| A. Injection-site reactions | Injection site infection 4 |
4 |
|
| A. Injection-site reactions | Musculoskeletal stiffness 4 |
4 |
|
| A. Injection-site reactions | Pallor 4 |
4 |
|
| A. Injection-site reactions | Sensory disturbance 4 |
4 |
|
| A. Injection-site reactions | Tenderness 4 |
4 |
|
| A. Injection-site reactions | Asthenia 3 |
3 |
|
| A. Injection-site reactions | Feeling hot 3 |
3 |
|
| A. Injection-site reactions | Inflammation 3 |
3 |
|
| A. Injection-site reactions | Injection site discharge 3 |
3 |
|
| A. Injection-site reactions | Injection site discolouration 3 |
3 |
|
| A. Injection-site reactions | Injection site irritation 3 |
3 |
|
| A. Injection-site reactions | Injection site reaction 3 |
3 |
|
| A. Injection-site reactions | Injection site urticaria 3 |
3 |
|
| A. Injection-site reactions | Injection site vesicles 3 |
3 |
|
| A. Injection-site reactions | Limb immobilisation 3 |
3 |
|
| A. Injection-site reactions | Musculoskeletal pain 3 |
3 |
|
| A. Injection-site reactions | Poor peripheral circulation 3 |
3 |
|
| A. Injection-site reactions | Sensory loss 3 |
3 |
|
| A. Injection-site reactions | Skin warm 3 |
3 |
|
| A. Injection-site reactions | Dry skin 2 |
2 |
|
| A. Injection-site reactions | Grip strength decreased 2 |
2 |
|
| A. Injection-site reactions | Hypoaesthesia 2 |
2 |
|
| A. Injection-site reactions | Injected limb mobility decreased 2 |
2 |
|
| A. Injection-site reactions | Injection site cellulitis 2 |
2 |
|
| A. Injection-site reactions | Injection site coldness 2 |
2 |
|
| A. Injection-site reactions | Injection site discolouration 2 |
2 |
|
| A. Injection-site reactions | Injection site mass 2 |
2 |
|
| A. Injection-site reactions | Injection site pain 2 |
2 |
|
| A. Injection-site reactions | Peripheral coldness 2 |
2 |
|
| A. Injection-site reactions | Pruritus 2 |
2 |
|
| A. Injection-site reactions | Sensory loss 2 |
2 |
|
| A. Injection-site reactions | Skin discolouration 2 |
2 |
|
| A. Injection-site reactions | Skin reaction 2 |
2 |
|
| A. Injection-site reactions | Skin reaction 2 |
2 |
|
| A. Injection-site reactions | Tenderness 2 |
2 |
|
| A. Injection-site reactions | Blister 1 |
1 |
|
| A. Injection-site reactions | Complex regional pain syndrome 1 |
1 |
|
| A. Injection-site reactions | Extensive swelling of vaccinated limb 1 |
1 |
|
| A. Injection-site reactions | Hyperaesthesia 1 |
1 |
|
| A. Injection-site reactions | Hyperaesthesia 1 |
1 |
|
| A. Injection-site reactions | Hypokinesia 1 |
1 |
|
| A. Injection-site reactions | Hypokinesia 1 |
1 |
|
| A. Injection-site reactions | Immobile 1 |
1 |
|
| A. Injection-site reactions | Impetigo 1 |
1 |
|
| A. Injection-site reactions | Injection site abscess 1 |
1 |
|
| A. Injection-site reactions | Injection site anaesthesia 1 |
1 |
|
| A. Injection-site reactions | Injection site coldness 1 |
1 |
|
| A. Injection-site reactions | Injection site discomfort 1 |
1 |
|
| A. Injection-site reactions | Injection site haematoma 1 |
1 |
|
| A. Injection-site reactions | Injection site haemorrhage 1 |
1 |
|
| A. Injection-site reactions | Injection site haemorrhage 1 |
1 |
|
| A. Injection-site reactions | Injection site joint movement impairment 1 |
1 |
|
| A. Injection-site reactions | Injection site joint pain 1 |
1 |
|
| A. Injection-site reactions | Injection site movement impairment 1 |
1 |
|
| A. Injection-site reactions | Injection site movement impairment 1 |
1 |
|
| A. Injection-site reactions | Injection site papule 1 |
1 |
|
| A. Injection-site reactions | Injection site paraesthesia 1 |
1 |
|
| A. Injection-site reactions | Injection site rash 1 |
1 |
|
| A. Injection-site reactions | Injection site scab 1 |
1 |
|
| A. Injection-site reactions | Joint swelling 1 |
1 |
|
| A. Injection-site reactions | Limb immobilisation 1 |
1 |
|
| A. Injection-site reactions | Local reaction 1 |
1 |
|
| A. Injection-site reactions | Local swelling 1 |
1 |
|
| A. Injection-site reactions | Lymphoedema 1 |
1 |
|
| A. Injection-site reactions | Mass 1 |
1 |
|
| A. Injection-site reactions | Mobility decreased 1 |
1 |
|
| A. Injection-site reactions | Muscle rigidity 1 |
1 |
|
| A. Injection-site reactions | Muscle spasms 1 |
1 |
|
| A. Injection-site reactions | Muscle tightness 1 |
1 |
|
| A. Injection-site reactions | Musculoskeletal pain 1 |
1 |
|
| A. Injection-site reactions | Nausea 1 |
1 |
|
| A. Injection-site reactions | Nodule 1 |
1 |
|
| A. Injection-site reactions | Pain of skin 1 |
1 |
|
| A. Injection-site reactions | Paraesthesia 1 |
1 |
|
| A. Injection-site reactions | Peripheral vascular disorder 1 |
1 |
|
| A. Injection-site reactions | Rash 1 |
1 |
|
| A. Injection-site reactions | Rash maculo-papular 1 |
1 |
|
| A. Injection-site reactions | Rash pruritic 1 |
1 |
|
| A. Injection-site reactions | Scab 1 |
1 |
|
| A. Injection-site reactions | Sensation of heaviness 1 |
1 |
|
| A. Injection-site reactions | Sensation of pressure 1 |
1 |
|
| A. Injection-site reactions | Tremor 1 |
1 |
|
| A. Injection-site reactions | Urticaria 1 |
1 |
|
| A. Injection-site reactions | Urticaria 1 |
1 |
|
| B. Allergic reactions | Rash 130 |
130 |
|
| B. Allergic reactions | Urticaria 89 |
89 |
|
| B. Allergic reactions | Pruritus 60 |
60 |
|
| B. Allergic reactions | Erythema 47 |
47 |
|
| B. Allergic reactions | Swelling face 42 |
42 |
|
| B. Allergic reactions | Anaphylactic reaction 41 |
41 |
|
| B. Allergic reactions | Dyspnoea 33 |
33 |
|
| B. Allergic reactions | Rash generalised 31 |
31 |
|
| B. Allergic reactions | Rash pruritic 31 |
31 |
|
| B. Allergic reactions | Oedema peripheral 29 |
29 |
|
| B. Allergic reactions | Lip swelling 26 |
26 |
|
| B. Allergic reactions | Rash macular 24 |
24 |
|
| B. Allergic reactions | Dizziness 23 |
23 |
|
| B. Allergic reactions | Hypersensitivity 22 |
22 |
|
| B. Allergic reactions | Eye swelling 18 |
18 |
|
| B. Allergic reactions | Paraesthesia oral 17 |
17 |
|
| B. Allergic reactions | Malaise 15 |
15 |
|
| B. Allergic reactions | Throat tightness 14 |
14 |
|
| B. Allergic reactions | Rash 13 |
13 |
|
| B. Allergic reactions | Swollen tongue 13 |
13 |
|
| B. Allergic reactions | Chest discomfort 11 |
11 |
|
| B. Allergic reactions | Rash erythematous 11 |
11 |
|
| B. Allergic reactions | Feeling hot 9 |
9 |
|
| B. Allergic reactions | Flushing 9 |
9 |
|
| B. Allergic reactions | Pruritus generalised 9 |
9 |
|
| B. Allergic reactions | Dermatitis allergic 8 |
8 |
|
| B. Allergic reactions | Pallor 8 |
8 |
|
| B. Allergic reactions | Pharyngeal oedema 8 |
8 |
|
| B. Allergic reactions | Urticaria 8 |
8 |
|
| B. Allergic reactions | Fatigue 7 |
7 |
|
| B. Allergic reactions | Oropharyngeal pain 7 |
7 |
|
| B. Allergic reactions | Paraesthesia 7 |
7 |
|
| B. Allergic reactions | Angioedema 6 |
6 |
|
| B. Allergic reactions | Dysphagia 6 |
6 |
|
| B. Allergic reactions | Headache 6 |
6 |
|
| B. Allergic reactions | Inflammation 6 |
6 |
|
| B. Allergic reactions | Pyrexia 6 |
6 |
|
| B. Allergic reactions | Throat irritation 6 |
6 |
|
| B. Allergic reactions | Blister 5 |
5 |
|
| B. Allergic reactions | Dyspnoea 5 |
5 |
|
| B. Allergic reactions | Hyperventilation 5 |
5 |
|
| B. Allergic reactions | Hypoaesthesia oral 5 |
5 |
|
| B. Allergic reactions | Vomiting 5 |
5 |
|
| B. Allergic reactions | Wheezing 5 |
5 |
|
| B. Allergic reactions | Anaphylactic shock 4 |
4 |
|
| B. Allergic reactions | Eyelid oedema 4 |
4 |
|
| B. Allergic reactions | Hypersensitivity 4 |
4 |
|
| B. Allergic reactions | Hypoaesthesia 4 |
4 |
|
| B. Allergic reactions | Local swelling 4 |
4 |
|
| B. Allergic reactions | Nausea 4 |
4 |
|
| B. Allergic reactions | Pain in extremity 4 |
4 |
|
| B. Allergic reactions | Dermatitis allergic 3 |
3 |
|
| B. Allergic reactions | Erythema 3 |
3 |
|
| B. Allergic reactions | Eye pruritus 3 |
3 |
|
| B. Allergic reactions | Eyelid oedema 3 |
3 |
|
| B. Allergic reactions | Hyperhidrosis 3 |
3 |
|
| B. Allergic reactions | Laryngeal oedema 3 |
3 |
|
| B. Allergic reactions | Limb discomfort 3 |
3 |
|
| B. Allergic reactions | Nasopharyngitis 3 |
3 |
|
| B. Allergic reactions | Ocular hyperaemia 3 |
3 |
|
| B. Allergic reactions | Pain 3 |
3 |
|
| B. Allergic reactions | Petechiae 3 |
3 |
|
| B. Allergic reactions | Rash erythematous 3 |
3 |
|
| B. Allergic reactions | Rash macular 3 |
3 |
|
| B. Allergic reactions | Rash maculo-papular 3 |
3 |
|
| B. Allergic reactions | Rash pruritic 3 |
3 |
|
| B. Allergic reactions | Skin irritation 3 |
3 |
|
| B. Allergic reactions | Skin reaction 3 |
3 |
|
| B. Allergic reactions | Somnolence 3 |
3 |
|
| B. Allergic reactions | Swelling 3 |
3 |
|
| B. Allergic reactions | Vision blurred 3 |
3 |
|
| B. Allergic reactions | Abdominal pain 2 |
2 |
|
| B. Allergic reactions | Abdominal pain upper 2 |
2 |
|
| B. Allergic reactions | Anaphylactic reaction 2 |
2 |
|
| B. Allergic reactions | Blister 2 |
2 |
|
| B. Allergic reactions | Body temperature increased 2 |
2 |
|
| B. Allergic reactions | Cold sweat 2 |
2 |
|
| B. Allergic reactions | Dermatitis contact 2 |
2 |
|
| B. Allergic reactions | Dizziness 2 |
2 |
|
| B. Allergic reactions | Face oedema 2 |
2 |
|
| B. Allergic reactions | Feeling cold 2 |
2 |
|
| B. Allergic reactions | Heart rate increased 2 |
2 |
|
| B. Allergic reactions | Heart rate irregular 2 |
2 |
|
| B. Allergic reactions | Heat rash 2 |
2 |
|
| B. Allergic reactions | Lip swelling 2 |
2 |
|
| B. Allergic reactions | Peripheral coldness 2 |
2 |
|
| B. Allergic reactions | Pharyngeal oedema 2 |
2 |
|
| B. Allergic reactions | Pruritus 2 |
2 |
|
| B. Allergic reactions | Rash generalised 2 |
2 |
|
| B. Allergic reactions | Skin discolouration 2 |
2 |
|
| B. Allergic reactions | Skin disorder 2 |
2 |
|
| B. Allergic reactions | Swollen tongue 2 |
2 |
|
| B. Allergic reactions | Tachycardia 2 |
2 |
|
| B. Allergic reactions | Type i hypersensitivity 2 |
2 |
|
| B. Allergic reactions | Anaphylactoid reaction 1 |
1 |
|
| B. Allergic reactions | Asthenia 1 |
1 |
|
| B. Allergic reactions | Asthenopia 1 |
1 |
|
| B. Allergic reactions | Asthma 1 |
1 |
|
| B. Allergic reactions | Back pain 1 |
1 |
|
| B. Allergic reactions | Breath sounds abnormal 1 |
1 |
|
| B. Allergic reactions | Bronchospasm 1 |
1 |
|
| B. Allergic reactions | Chest pain 1 |
1 |
|
| B. Allergic reactions | Chills 1 |
1 |
|
| B. Allergic reactions | Condition aggravated 1 |
1 |
|
| B. Allergic reactions | Confusional state 1 |
1 |
|
| B. Allergic reactions | Conjunctival hyperaemia 1 |
1 |
|
| B. Allergic reactions | Contusion 1 |
1 |
|
| B. Allergic reactions | Convulsion 1 |
1 |
|
| B. Allergic reactions | Cough 1 |
1 |
|
| B. Allergic reactions | Dermatitis 1 |
1 |
|
| B. Allergic reactions | Dry throat 1 |
1 |
|
| B. Allergic reactions | Dysphagia 1 |
1 |
|
| B. Allergic reactions | Eczema 1 |
1 |
|
| B. Allergic reactions | Eczema 1 |
1 |
|
| B. Allergic reactions | Eyelid disorder 1 |
1 |
|
| B. Allergic reactions | Eyes sunken 1 |
1 |
|
| B. Allergic reactions | Fatigue 1 |
1 |
|
| B. Allergic reactions | Feeling abnormal 1 |
1 |
|
| B. Allergic reactions | Feeling hot 1 |
1 |
|
| B. Allergic reactions | Feeling jittery 1 |
1 |
|
| B. Allergic reactions | Generalised erythema 1 |
1 |
|
| B. Allergic reactions | Gingival swelling 1 |
1 |
|
| B. Allergic reactions | Headache 1 |
1 |
|
| B. Allergic reactions | Hypersomnia 1 |
1 |
|
| B. Allergic reactions | Hypertension 1 |
1 |
|
| B. Allergic reactions | Hypoventilation 1 |
1 |
|
| B. Allergic reactions | Increased bronchial secretion 1 |
1 |
|
| B. Allergic reactions | Infusion site swelling 1 |
1 |
|
| B. Allergic reactions | Laryngeal oedema 1 |
1 |
|
| B. Allergic reactions | Lethargy 1 |
1 |
|
| B. Allergic reactions | Lip blister 1 |
1 |
|
| B. Allergic reactions | Lip ulceration 1 |
1 |
|
| B. Allergic reactions | Local reaction 1 |
1 |
|
| B. Allergic reactions | Loss of consciousness 1 |
1 |
|
| B. Allergic reactions | Migraine 1 |
1 |
|
| B. Allergic reactions | Muscle tightness 1 |
1 |
|
| B. Allergic reactions | Musculoskeletal stiffness 1 |
1 |
|
| B. Allergic reactions | Myalgia 1 |
1 |
|
| B. Allergic reactions | Mydriasis 1 |
1 |
|
| B. Allergic reactions | Nausea 1 |
1 |
|
| B. Allergic reactions | Neck pain 1 |
1 |
|
| B. Allergic reactions | Oedema mouth 1 |
1 |
|
| B. Allergic reactions | Oedema mouth 1 |
1 |
|
| B. Allergic reactions | Oesophageal discomfort 1 |
1 |
|
| B. Allergic reactions | Oral discomfort 1 |
1 |
|
| B. Allergic reactions | Oral pain 1 |
1 |
|
| B. Allergic reactions | Palpitations 1 |
1 |
|
| B. Allergic reactions | Panic reaction 1 |
1 |
|
| B. Allergic reactions | Paraesthesia oral 1 |
1 |
|
| B. Allergic reactions | Periorbital oedema 1 |
1 |
|
| B. Allergic reactions | Photophobia 1 |
1 |
|
| B. Allergic reactions | Piloerection 1 |
1 |
|
| B. Allergic reactions | Pulse absent 1 |
1 |
|
| B. Allergic reactions | Purpura 1 |
1 |
|
| B. Allergic reactions | Pyrexia 1 |
1 |
|
| B. Allergic reactions | Rash follicular 1 |
1 |
|
| B. Allergic reactions | Rash papular 1 |
1 |
|
| B. Allergic reactions | Respiratory rate increased 1 |
1 |
|
| B. Allergic reactions | Sensation of foreign body 1 |
1 |
|
| B. Allergic reactions | Sneezing 1 |
1 |
|
| B. Allergic reactions | Somnolence 1 |
1 |
|
| B. Allergic reactions | Speech disorder 1 |
1 |
|
| B. Allergic reactions | Stridor 1 |
1 |
|
| B. Allergic reactions | Swelling 1 |
1 |
|
| B. Allergic reactions | Swelling face 1 |
1 |
|
| B. Allergic reactions | Syncope 1 |
1 |
|
| B. Allergic reactions | Systemic lupus erythematosus rash 1 |
1 |
|
| B. Allergic reactions | Tenderness 1 |
1 |
|
| B. Allergic reactions | Thirst 1 |
1 |
|
| B. Allergic reactions | Throat irritation 1 |
1 |
|
| B. Allergic reactions | Throat tightness 1 |
1 |
|
| B. Allergic reactions | Tremor 1 |
1 |
|
| B. Allergic reactions | Type IV hypersensitivity reaction 1 |
1 |
|
| B. Allergic reactions | Urticaria pigmentosa 1 |
1 |
|
| B. Allergic reactions | Visual impairment 1 |
1 |
|
| B. Allergic reactions | Vomiting 1 |
1 |
|
| C. ‘Psychogenic’ events | Dizziness 327 |
327 |
|
| C. ‘Psychogenic’ events | Syncope 296 |
296 |
|
| C. ‘Psychogenic’ events | Nausea 151 |
151 |
|
| C. ‘Psychogenic’ events | Headache 109 |
109 |
|
| C. ‘Psychogenic’ events | Pallor 108 |
108 |
|
| C. ‘Psychogenic’ events | Vomiting 77 |
77 |
|
| C. ‘Psychogenic’ events | Malaise 74 |
74 |
|
| C. ‘Psychogenic’ events | Tremor 61 |
61 |
|
| C. ‘Psychogenic’ events | Vision blurred 46 |
46 |
|
| C. ‘Psychogenic’ events | Feeling hot 45 |
45 |
|
| C. ‘Psychogenic’ events | Flushing 40 |
40 |
|
| C. ‘Psychogenic’ events | Cold sweat 35 |
35 |
|
| C. ‘Psychogenic’ events | Syncope 27 |
27 |
|
| C. ‘Psychogenic’ events | Hyperhidrosis 25 |
25 |
|
| C. ‘Psychogenic’ events | Presyncope 23 |
23 |
|
| C. ‘Psychogenic’ events | Hyperventilation 21 |
21 |
|
| C. ‘Psychogenic’ events | Loss of consciousness 19 |
19 |
|
| C. ‘Psychogenic’ events | Dyspnoea 18 |
18 |
|
| C. ‘Psychogenic’ events | Paraesthesia 18 |
18 |
|
| C. ‘Psychogenic’ events | Chills 17 |
17 |
|
| C. ‘Psychogenic’ events | Convulsion 17 |
17 |
|
| C. ‘Psychogenic’ events | Pyrexia 16 |
16 |
|
| C. ‘Psychogenic’ events | Somnolence 16 |
16 |
|
| C. ‘Psychogenic’ events | Dizziness 15 |
15 |
|
| C. ‘Psychogenic’ events | Fatigue 15 |
15 |
|
| C. ‘Psychogenic’ events | Heart rate increased 14 |
14 |
|
| C. ‘Psychogenic’ events | Unresponsive to stimuli 14 |
14 |
|
| C. ‘Psychogenic’ events | Muscle twitching 13 |
13 |
|
| C. ‘Psychogenic’ events | Rash 13 |
13 |
|
| C. ‘Psychogenic’ events | Asthenia 12 |
12 |
|
| C. ‘Psychogenic’ events | Feeling cold 12 |
12 |
|
| C. ‘Psychogenic’ events | Hypoaesthesia 12 |
12 |
|
| C. ‘Psychogenic’ events | Panic attack 12 |
12 |
|
| C. ‘Psychogenic’ events | Chest discomfort 11 |
11 |
|
| C. ‘Psychogenic’ events | Dyskinesia 11 |
11 |
|
| C. ‘Psychogenic’ events | Eye rolling 11 |
11 |
|
| C. ‘Psychogenic’ events | Tachycardia 11 |
11 |
|
| C. ‘Psychogenic’ events | Tearfulness 11 |
11 |
|
| C. ‘Psychogenic’ events | Nervousness 10 |
10 |
|
| C. ‘Psychogenic’ events | Erythema 9 |
9 |
|
| C. ‘Psychogenic’ events | Headache 9 |
9 |
|
| C. ‘Psychogenic’ events | Rash macular 9 |
9 |
|
| C. ‘Psychogenic’ events | Abdominal pain 8 |
8 |
|
| C. ‘Psychogenic’ events | Chest pain 8 |
8 |
|
| C. ‘Psychogenic’ events | Peripheral coldness 8 |
8 |
|
| C. ‘Psychogenic’ events | Abdominal pain upper 7 |
7 |
|
| C. ‘Psychogenic’ events | Anxiety 7 |
7 |
|
| C. ‘Psychogenic’ events | Fall 7 |
7 |
|
| C. ‘Psychogenic’ events | Hypotension 7 |
7 |
|
| C. ‘Psychogenic’ events | Lethargy 7 |
7 |
|
| C. ‘Psychogenic’ events | Muscular weakness 7 |
7 |
|
| C. ‘Psychogenic’ events | Photophobia 7 |
7 |
|
| C. ‘Psychogenic’ events | Visual impairment 7 |
7 |
|
| C. ‘Psychogenic’ events | Confusional state 6 |
6 |
|
| C. ‘Psychogenic’ events | Deafness 6 |
6 |
|
| C. ‘Psychogenic’ events | Feeling of body temperature change 6 |
6 |
|
| C. ‘Psychogenic’ events | Muscle rigidity 6 |
6 |
|
| C. ‘Psychogenic’ events | Musculoskeletal stiffness 6 |
6 |
|
| C. ‘Psychogenic’ events | Mydriasis 6 |
6 |
|
| C. ‘Psychogenic’ events | Nasopharyngitis 6 |
6 |
|
| C. ‘Psychogenic’ events | Throat tightness 6 |
6 |
|
| C. ‘Psychogenic’ events | Dizziness postural 5 |
5 |
|
| C. ‘Psychogenic’ events | Dysgeusia 5 |
5 |
|
| C. ‘Psychogenic’ events | Feeling abnormal 5 |
5 |
|
| C. ‘Psychogenic’ events | Pallor 5 |
5 |
|
| C. ‘Psychogenic’ events | Skin discolouration 5 |
5 |
|
| C. ‘Psychogenic’ events | Urticaria 5 |
5 |
|
| C. ‘Psychogenic’ events | Abdominal discomfort 4 |
4 |
|
| C. ‘Psychogenic’ events | Blindness transient 4 |
4 |
|
| C. ‘Psychogenic’ events | Body temperature increased 4 |
4 |
|
| C. ‘Psychogenic’ events | Decreased appetite 4 |
4 |
|
| C. ‘Psychogenic’ events | Hot flush 4 |
4 |
|
| C. ‘Psychogenic’ events | Migraine 4 |
4 |
|
| C. ‘Psychogenic’ events | Muscle spasms 4 |
4 |
|
| C. ‘Psychogenic’ events | Pulse abnormal 4 |
4 |
|
| C. ‘Psychogenic’ events | Respiratory rate increased 4 |
4 |
|
| C. ‘Psychogenic’ events | Tinnitus 4 |
4 |
|
| C. ‘Psychogenic’ events | Urinary incontinence 4 |
4 |
|
| C. ‘Psychogenic’ events | Vomiting 4 |
4 |
|
| C. ‘Psychogenic’ events | Abasia 3 |
3 |
|
| C. ‘Psychogenic’ events | Agitation 3 |
3 |
|
| C. ‘Psychogenic’ events | Balance disorder 3 |
3 |
|
| C. ‘Psychogenic’ events | Blindness 3 |
3 |
|
| C. ‘Psychogenic’ events | Blood pressure decreased 3 |
3 |
|
| C. ‘Psychogenic’ events | Cyanosis 3 |
3 |
|
| C. ‘Psychogenic’ events | Disorientation 3 |
3 |
|
| C. ‘Psychogenic’ events | Disturbance in attention 3 |
3 |
|
| C. ‘Psychogenic’ events | Dyspnoea 3 |
3 |
|
| C. ‘Psychogenic’ events | Dysstasia 3 |
3 |
|
| C. ‘Psychogenic’ events | Emotional disorder 3 |
3 |
|
| C. ‘Psychogenic’ events | Feeling drunk 3 |
3 |
|
| C. ‘Psychogenic’ events | Hearing impaired 3 |
3 |
|
| C. ‘Psychogenic’ events | Heart rate irregular 3 |
3 |
|
| C. ‘Psychogenic’ events | Hypoventilation 3 |
3 |
|
| C. ‘Psychogenic’ events | Nausea 3 |
3 |
|
| C. ‘Psychogenic’ events | Pain 3 |
3 |
|
| C. ‘Psychogenic’ events | Pain in extremity 3 |
3 |
|
| C. ‘Psychogenic’ events | Panic reaction 3 |
3 |
|
| C. ‘Psychogenic’ events | Rash 3 |
3 |
|
| C. ‘Psychogenic’ events | Sensory loss 3 |
3 |
|
| C. ‘Psychogenic’ events | Somnolence 3 |
3 |
|
| C. ‘Psychogenic’ events | Throat irritation 3 |
3 |
|
| C. ‘Psychogenic’ events | Vertigo 3 |
3 |
|
| C. ‘Psychogenic’ events | Amnesia 2 |
2 |
|
| C. ‘Psychogenic’ events | Blood pressure increased 2 |
2 |
|
| C. ‘Psychogenic’ events | Body temperature decreased 2 |
2 |
|
| C. ‘Psychogenic’ events | Bradycardia 2 |
2 |
|
| C. ‘Psychogenic’ events | Circulatory collapse 2 |
2 |
|
| C. ‘Psychogenic’ events | Colour blindness acquired 2 |
2 |
|
| C. ‘Psychogenic’ events | Consciousness fluctuating 2 |
2 |
|
| C. ‘Psychogenic’ events | Diplopia 2 |
2 |
|
| C. ‘Psychogenic’ events | Dry mouth 2 |
2 |
|
| C. ‘Psychogenic’ events | Dry throat 2 |
2 |
|
| C. ‘Psychogenic’ events | Dysarthria 2 |
2 |
|
| C. ‘Psychogenic’ events | Dysphagia 2 |
2 |
|
| C. ‘Psychogenic’ events | Emotional distress 2 |
2 |
|
| C. ‘Psychogenic’ events | Heart rate decreased 2 |
2 |
|
| C. ‘Psychogenic’ events | Heart rate increased 2 |
2 |
|
| C. ‘Psychogenic’ events | Hypertension 2 |
2 |
|
| C. ‘Psychogenic’ events | Hyperventilation 2 |
2 |
|
| C. ‘Psychogenic’ events | Hypoacusis 2 |
2 |
|
| C. ‘Psychogenic’ events | Malaise 2 |
2 |
|
| C. ‘Psychogenic’ events | Muscular weakness 2 |
2 |
|
| C. ‘Psychogenic’ events | Myalgia 2 |
2 |
|
| C. ‘Psychogenic’ events | Neck pain 2 |
2 |
|
| C. ‘Psychogenic’ events | Oropharyngeal pain 2 |
2 |
|
| C. ‘Psychogenic’ events | Paraesthesia oral 2 |
2 |
|
| C. ‘Psychogenic’ events | Presyncope 2 |
2 |
|
| C. ‘Psychogenic’ events | Procedural dizziness 2 |
2 |
|
| C. ‘Psychogenic’ events | Pruritus 2 |
2 |
|
| C. ‘Psychogenic’ events | Pulse pressure decreased 2 |
2 |
|
| C. ‘Psychogenic’ events | Pupil fixed 2 |
2 |
|
| C. ‘Psychogenic’ events | Rash generalised 2 |
2 |
|
| C. ‘Psychogenic’ events | Retching 2 |
2 |
|
| C. ‘Psychogenic’ events | Salivary hypersecretion 2 |
2 |
|
| C. ‘Psychogenic’ events | Shock 2 |
2 |
|
| C. ‘Psychogenic’ events | Vision blurred 2 |
2 |
|
| C. ‘Psychogenic’ events | Abdominal discomfort 1 |
1 |
|
| C. ‘Psychogenic’ events | Abdominal distension 1 |
1 |
|
| C. ‘Psychogenic’ events | Abdominal pain 1 |
1 |
|
| C. ‘Psychogenic’ events | Abnormal behaviour 1 |
1 |
|
| C. ‘Psychogenic’ events | Altered state of consciousness 1 |
1 |
|
| C. ‘Psychogenic’ events | Aphasia 1 |
1 |
|
| C. ‘Psychogenic’ events | Asthenia 1 |
1 |
|
| C. ‘Psychogenic’ events | Asthma 1 |
1 |
|
| C. ‘Psychogenic’ events | Back pain 1 |
1 |
|
| C. ‘Psychogenic’ events | Blindness transient 1 |
1 |
|
| C. ‘Psychogenic’ events | Blood pressure increased 1 |
1 |
|
| C. ‘Psychogenic’ events | Blood pressure systolic decreased 1 |
1 |
|
| C. ‘Psychogenic’ events | Body temperature decreased 1 |
1 |
|
| C. ‘Psychogenic’ events | Bruxism 1 |
1 |
|
| C. ‘Psychogenic’ events | Burning sensation 1 |
1 |
|
| C. ‘Psychogenic’ events | Chills 1 |
1 |
|
| C. ‘Psychogenic’ events | Condition aggravated 1 |
1 |
|
| C. ‘Psychogenic’ events | Convulsion 1 |
1 |
|
| C. ‘Psychogenic’ events | Cough 1 |
1 |
|
| C. ‘Psychogenic’ events | Deafness transitory 1 |
1 |
|
| C. ‘Psychogenic’ events | Depressed level of consciousness 1 |
1 |
|
| C. ‘Psychogenic’ events | Discomfort 1 |
1 |
|
| C. ‘Psychogenic’ events | Dissociation 1 |
1 |
|
| C. ‘Psychogenic’ events | Disturbance in attention 1 |
1 |
|
| C. ‘Psychogenic’ events | Dry mouth 1 |
1 |
|
| C. ‘Psychogenic’ events | Ear discomfort 1 |
1 |
|
| C. ‘Psychogenic’ events | Ear pain 1 |
1 |
|
| C. ‘Psychogenic’ events | Epistaxis 1 |
1 |
|
| C. ‘Psychogenic’ events | Eye pain 1 |
1 |
|
| C. ‘Psychogenic’ events | Eyelid oedema 1 |
1 |
|
| C. ‘Psychogenic’ events | Face injury 1 |
1 |
|
| C. ‘Psychogenic’ events | Facial spasm 1 |
1 |
|
| C. ‘Psychogenic’ events | Fatigue 1 |
1 |
|
| C. ‘Psychogenic’ events | Fear 1 |
1 |
|
| C. ‘Psychogenic’ events | Feeling of despair 1 |
1 |
|
| C. ‘Psychogenic’ events | Foaming at mouth 1 |
1 |
|
| C. ‘Psychogenic’ events | Gait disturbance 1 |
1 |
|
| C. ‘Psychogenic’ events | Grand mal convulsion 1 |
1 |
|
| C. ‘Psychogenic’ events | Grip strength decreased 1 |
1 |
|
| C. ‘Psychogenic’ events | Head banging 1 |
1 |
|
| C. ‘Psychogenic’ events | Head discomfort 1 |
1 |
|
| C. ‘Psychogenic’ events | Heart rate irregular 1 |
1 |
|
| C. ‘Psychogenic’ events | Heat rash 1 |
1 |
|
| C. ‘Psychogenic’ events | Hemiparesis 1 |
1 |
|
| C. ‘Psychogenic’ events | Hot flush 1 |
1 |
|
| C. ‘Psychogenic’ events | Hyperhidrosis 1 |
1 |
|
| C. ‘Psychogenic’ events | Hypersomnia 1 |
1 |
|
| C. ‘Psychogenic’ events | Hypoaesthesia 1 |
1 |
|
| C. ‘Psychogenic’ events | Hypoaesthesia facial 1 |
1 |
|
| C. ‘Psychogenic’ events | Hypokinesia 1 |
1 |
|
| C. ‘Psychogenic’ events | Hypotonia 1 |
1 |
|
| C. ‘Psychogenic’ events | Incontinence 1 |
1 |
|
| C. ‘Psychogenic’ events | Lip swelling 1 |
1 |
|
| C. ‘Psychogenic’ events | Livedo reticularis 1 |
1 |
|
| C. ‘Psychogenic’ events | Migraine 1 |
1 |
|
| C. ‘Psychogenic’ events | Muscle contracture 1 |
1 |
|
| C. ‘Psychogenic’ events | Myoclonus 1 |
1 |
|
| C. ‘Psychogenic’ events | Nervous system disorder 1 |
1 |
|
| C. ‘Psychogenic’ events | Oral discomfort 1 |
1 |
|
| C. ‘Psychogenic’ events | Palpitations 1 |
1 |
|
| C. ‘Psychogenic’ events | Paraesthesia 1 |
1 |
|
| C. ‘Psychogenic’ events | Peripheral circulatory failure 1 |
1 |
|
| C. ‘Psychogenic’ events | Pharyngeal oedema 1 |
1 |
|
| C. ‘Psychogenic’ events | Photophobia 1 |
1 |
|
| C. ‘Psychogenic’ events | Poor peripheral circulation 1 |
1 |
|
| C. ‘Psychogenic’ events | Pruritus 1 |
1 |
|
| C. ‘Psychogenic’ events | Psychomotor hyperactivity 1 |
1 |
|
| C. ‘Psychogenic’ events | Pyrexia 1 |
1 |
|
| C. ‘Psychogenic’ events | Respiratory arrest 1 |
1 |
|
| C. ‘Psychogenic’ events | Respiratory rate decreased 1 |
1 |
|
| C. ‘Psychogenic’ events | Seizure anoxic 1 |
1 |
|
| C. ‘Psychogenic’ events | Sensation of heaviness 1 |
1 |
|
| C. ‘Psychogenic’ events | Sensory loss 1 |
1 |
|
| C. ‘Psychogenic’ events | Sinus tachycardia 1 |
1 |
|
| C. ‘Psychogenic’ events | Sleep attacks 1 |
1 |
|
| C. ‘Psychogenic’ events | Sudden onset of sleep 1 |
1 |
|
| C. ‘Psychogenic’ events | Tachypnoea 1 |
1 |
|
| C. ‘Psychogenic’ events | Tremor 1 |
1 |
|
| C. ‘Psychogenic’ events | Urticaria 1 |
1 |
|
| C. ‘Psychogenic’ events | Visual impairment 1 |
1 |
|
| D. ‘Other recognised’ reactions | Nausea 631 |
631 |
|
| D. ‘Other recognised’ reactions | Headache 629 |
629 |
|
| D. ‘Other recognised’ reactions | Dizziness 625 |
625 |
|
| D. ‘Other recognised’ reactions | Vomiting 260 |
260 |
|
| D. ‘Other recognised’ reactions | Malaise 220 |
220 |
|
| D. ‘Other recognised’ reactions | Fatigue 216 |
216 |
|
| D. ‘Other recognised’ reactions | Pyrexia 175 |
175 |
|
| D. ‘Other recognised’ reactions | Abdominal pain 69 |
69 |
|
| D. ‘Other recognised’ reactions | Diarrhoea 55 |
55 |
|
| D. ‘Other recognised’ reactions | Abdominal pain upper 54 |
54 |
|
| D. ‘Other recognised’ reactions | Myalgia 49 |
49 |
|
| D. ‘Other recognised’ reactions | Lethargy 48 |
48 |
|
| D. ‘Other recognised’ reactions | Feeling hot 43 |
43 |
|
| D. ‘Other recognised’ reactions | Body temperature increased 36 |
36 |
|
| D. ‘Other recognised’ reactions | Pain 34 |
34 |
|
| D. ‘Other recognised’ reactions | Headache 30 |
30 |
|
| D. ‘Other recognised’ reactions | Influenza like illness 28 |
28 |
|
| D. ‘Other recognised’ reactions | Nausea 28 |
28 |
|
| D. ‘Other recognised’ reactions | Oropharyngeal pain 28 |
28 |
|
| D. ‘Other recognised’ reactions | Arthralgia 25 |
25 |
|
| D. ‘Other recognised’ reactions | Malaise 25 |
25 |
|
| D. ‘Other recognised’ reactions | Pyrexia 24 |
24 |
|
| D. ‘Other recognised’ reactions | Pallor 22 |
22 |
|
| D. ‘Other recognised’ reactions | Somnolence 22 |
22 |
|
| D. ‘Other recognised’ reactions | Asthenia 21 |
21 |
|
| D. ‘Other recognised’ reactions | Chills 21 |
21 |
|
| D. ‘Other recognised’ reactions | Pain in extremity 21 |
21 |
|
| D. ‘Other recognised’ reactions | Rash 21 |
21 |
|
| Musculoskeletal and connective tissue disorders | D. ‘Other recognised’ reactions | Arthralgia 20 |
20 |
| D. ‘Other recognised’ reactions | Lymphadenopathy 18 |
18 |
|
| D. ‘Other recognised’ reactions | Vomiting 16 |
16 |
|
| D. ‘Other recognised’ reactions | Abdominal discomfort 15 |
15 |
|
| D. ‘Other recognised’ reactions | Dizziness 15 |
15 |
|
| D. ‘Other recognised’ reactions | Flushing 14 |
14 |
|
| D. ‘Other recognised’ reactions | Paraesthesia 14 |
14 |
|
| D. ‘Other recognised’ reactions | Fatigue 12 |
12 |
|
| D. ‘Other recognised’ reactions | Tremor 12 |
12 |
|
| D. ‘Other recognised’ reactions | Pruritus 11 |
11 |
|
| D. ‘Other recognised’ reactions | Decreased appetite 10 |
10 |
|
| D. ‘Other recognised’ reactions | Abdominal pain 8 |
8 |
|
| D. ‘Other recognised’ reactions | Neck pain 8 |
8 |
|
| D. ‘Other recognised’ reactions | Feeling cold 7 |
7 |
|
| D. ‘Other recognised’ reactions | Back pain 6 |
6 |
|
| D. ‘Other recognised’ reactions | Cough 6 |
6 |
|
| D. ‘Other recognised’ reactions | Hyperhidrosis 6 |
6 |
|
| D. ‘Other recognised’ reactions | Hypoaesthesia 6 |
6 |
|
| D. ‘Other recognised’ reactions | Lethargy 6 |
6 |
|
| D. ‘Other recognised’ reactions | Musculoskeletal stiffness 6 |
6 |
|
| D. ‘Other recognised’ reactions | Nasopharyngitis 6 |
6 |
|
| D. ‘Other recognised’ reactions | Abdominal pain upper 5 |
5 |
|
| D. ‘Other recognised’ reactions | Asthenia 4 |
4 |
|
| D. ‘Other recognised’ reactions | Body temperature increased 4 |
4 |
|
| D. ‘Other recognised’ reactions | Erythema 4 |
4 |
|
| D. ‘Other recognised’ reactions | Feeling of body temperature change 4 |
4 |
|
| D. ‘Other recognised’ reactions | Migraine 4 |
4 |
|
| D. ‘Other recognised’ reactions | Myalgia 4 |
4 |
|
| D. ‘Other recognised’ reactions | Nervousness 4 |
4 |
|
| D. ‘Other recognised’ reactions | Back pain 3 |
3 |
|
| D. ‘Other recognised’ reactions | Decreased appetite 3 |
3 |
|
| D. ‘Other recognised’ reactions | Diarrhoea 3 |
3 |
|
| D. ‘Other recognised’ reactions | Lower respiratory tract infection 3 |
3 |
|
| D. ‘Other recognised’ reactions | Muscle fatigue 3 |
3 |
|
| D. ‘Other recognised’ reactions | Muscular weakness 3 |
3 |
|
| D. ‘Other recognised’ reactions | Rash generalised 3 |
3 |
|
| D. ‘Other recognised’ reactions | Somnolence 3 |
3 |
|
| D. ‘Other recognised’ reactions | Cold sweat 2 |
2 |
|
| D. ‘Other recognised’ reactions | Dizziness postural 2 |
2 |
|
| D. ‘Other recognised’ reactions | Feeling abnormal 2 |
2 |
|
| D. ‘Other recognised’ reactions | Gait disturbance 2 |
2 |
|
| D. ‘Other recognised’ reactions | Head discomfort 2 |
2 |
|
| D. ‘Other recognised’ reactions | Hot flush 2 |
2 |
|
| D. ‘Other recognised’ reactions | Influenza like illness 2 |
2 |
|
| D. ‘Other recognised’ reactions | Joint swelling 2 |
2 |
|
| D. ‘Other recognised’ reactions | Limb discomfort 2 |
2 |
|
| D. ‘Other recognised’ reactions | Listless 2 |
2 |
|
| D. ‘Other recognised’ reactions | Local reaction 2 |
2 |
|
| D. ‘Other recognised’ reactions | Musculoskeletal stiffness 2 |
2 |
|
| D. ‘Other recognised’ reactions | Nasal congestion 2 |
2 |
|
| D. ‘Other recognised’ reactions | Oropharyngeal pain 2 |
2 |
|
| D. ‘Other recognised’ reactions | Pain 2 |
2 |
|
| D. ‘Other recognised’ reactions | Pruritus generalised 2 |
2 |
|
| D. ‘Other recognised’ reactions | Rash macular 2 |
2 |
|
| D. ‘Other recognised’ reactions | Skin warm 2 |
2 |
|
| D. ‘Other recognised’ reactions | Throat irritation 2 |
2 |
|
| D. ‘Other recognised’ reactions | Abdominal pain lower 1 |
1 |
|
| D. ‘Other recognised’ reactions | Abdominal pain lower 1 |
1 |
|
| D. ‘Other recognised’ reactions | Arthralgia 1 |
1 |
|
| D. ‘Other recognised’ reactions | Axillary mass 1 |
1 |
|
| D. ‘Other recognised’ reactions | Bedridden 1 |
1 |
|
| D. ‘Other recognised’ reactions | Body temperature 1 |
1 |
|
| D. ‘Other recognised’ reactions | Body temperature fluctuation 1 |
1 |
|
| D. ‘Other recognised’ reactions | Body temperature fluctuation 1 |
1 |
|
| D. ‘Other recognised’ reactions | Cough 1 |
1 |
|
| D. ‘Other recognised’ reactions | Dyspnoea 1 |
1 |
|
| D. ‘Other recognised’ reactions | Feeling of body temperature change 1 |
1 |
|
| D. ‘Other recognised’ reactions | Gastrointestinal disorder 1 |
1 |
|
| D. ‘Other recognised’ reactions | Generalised erythema 1 |
1 |
|
| D. ‘Other recognised’ reactions | Groin pain 1 |
1 |
|
| D. ‘Other recognised’ reactions | Hot flush 1 |
1 |
|
| D. ‘Other recognised’ reactions | Hypoaesthesia 1 |
1 |
|
| D. ‘Other recognised’ reactions | Hypotension 1 |
1 |
|
| D. ‘Other recognised’ reactions | Ill-defined disorder 1 |
1 |
|
| D. ‘Other recognised’ reactions | Immunisation reaction 1 |
1 |
|
| D. ‘Other recognised’ reactions | Induration 1 |
1 |
|
| D. ‘Other recognised’ reactions | Insomnia 1 |
1 |
|
| D. ‘Other recognised’ reactions | Limb discomfort 1 |
1 |
|
| D. ‘Other recognised’ reactions | Local reaction 1 |
1 |
|
| D. ‘Other recognised’ reactions | Local swelling 1 |
1 |
|
| D. ‘Other recognised’ reactions | Loss of consciousness 1 |
1 |
|
| D. ‘Other recognised’ reactions | Lymphadenopathy 1 |
1 |
|
| D. ‘Other recognised’ reactions | Mobility decreased 1 |
1 |
|
| D. ‘Other recognised’ reactions | Muscle spasms 1 |
1 |
|
| D. ‘Other recognised’ reactions | Muscle twitching 1 |
1 |
|
| D. ‘Other recognised’ reactions | Musculoskeletal chest pain 1 |
1 |
|
| D. ‘Other recognised’ reactions | Musculoskeletal discomfort 1 |
1 |
|
| D. ‘Other recognised’ reactions | Musculoskeletal discomfort 1 |
1 |
|
| D. ‘Other recognised’ reactions | Musculoskeletal pain 1 |
1 |
|
| D. ‘Other recognised’ reactions | Neck pain 1 |
1 |
|
| D. ‘Other recognised’ reactions | Night sweats 1 |
1 |
|
| D. ‘Other recognised’ reactions | Pain in extremity 1 |
1 |
|
| D. ‘Other recognised’ reactions | Peripheral coldness 1 |
1 |
|
| D. ‘Other recognised’ reactions | Pharyngitis 1 |
1 |
|
| D. ‘Other recognised’ reactions | Rash erythematous 1 |
1 |
|
| D. ‘Other recognised’ reactions | Respiratory disorder 1 |
1 |
|
| D. ‘Other recognised’ reactions | Respiratory tract infection 1 |
1 |
|
| D. ‘Other recognised’ reactions | Restlessness 1 |
1 |
|
| D. ‘Other recognised’ reactions | Rhinorrhoea 1 |
1 |
|
| D. ‘Other recognised’ reactions | Sensation of heaviness 1 |
1 |
|
| D. ‘Other recognised’ reactions | Sudden onset of sleep 1 |
1 |
|
| D. ‘Other recognised’ reactions | Swelling 1 |
1 |
|
| D. ‘Other recognised’ reactions | Swelling face 1 |
1 |
|
| D. ‘Other recognised’ reactions | Syncope 1 |
1 |
|
| D. ‘Other recognised’ reactions | Thirst 1 |
1 |
|
| D. ‘Other recognised’ reactions | Throat tightness 1 |
1 |
|
| D. ‘Other recognised’ reactions | Upper respiratory tract infection 1 |
1 |
|
| D. ‘Other recognised’ reactions | Urticaria 1 |
1 |
|
| D. ‘Other recognised’ reactions | Weight decreased 1 |
1 |
|
| Nervous system disorders | E. not currently recognised | Headache 47 |
47 |
| Nervous system disorders | E. not currently recognised | Syncope 35 |
35 |
| General disorders and administration site conditions | E. not currently recognised | Influenza like illness 32 |
32 |
| Nervous system disorders | E. not currently recognised | Dizziness 29 |
29 |
| Nervous system disorders | E. not currently recognised | Hypoaesthesia 29 |
29 |
| Nervous system disorders | E. not currently recognised | Convulsion 28 |
28 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Pain in extremity 27 |
27 |
| Gastrointestinal disorders | E. not currently recognised | Nausea 24 |
24 |
| Nervous system disorders | E. not currently recognised | Paraesthesia 20 |
20 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Dyspnoea 19 |
19 |
| Nervous system disorders | E. not currently recognised | Lethargy 19 |
19 |
| General disorders and administration site conditions | E. not currently recognised | Malaise 19 |
19 |
| Injury, poisoning and procedural complications | E. not currently recognised | Drug exposure during pregnancy 18 |
18 |
| General disorders and administration site conditions | E. not currently recognised | Fatigue 18 |
18 |
| General disorders and administration site conditions | E. not currently recognised | Pyrexia 18 |
18 |
| General disorders and administration site conditions | E. not currently recognised | Chest pain 17 |
17 |
| Gastrointestinal disorders | E. not currently recognised | Vomiting 17 |
17 |
| Nervous system disorders | E. not currently recognised | Migraine 16 |
16 |
| General disorders and administration site conditions | E. not currently recognised | Pain 16 |
16 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Back pain 15 |
15 |
| Nervous system disorders | E. not currently recognised | Somnolence 14 |
14 |
| Nervous system disorders | E. not currently recognised | Tremor 14 |
14 |
| Nervous system disorders | E. not currently recognised | Dizziness 12 |
12 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Muscular weakness 12 |
12 |
| Pregnancy, puerperium and perinatal conditions | E. not currently recognised | Abortion spontaneous 11 |
11 |
| General disorders and administration site conditions | E. not currently recognised | Asthenia 11 |
11 |
| Nervous system disorders | E. not currently recognised | Headache 11 |
11 |
| Nervous system disorders | E. not currently recognised | Loss of consciousness 11 |
11 |
| Gastrointestinal disorders | E. not currently recognised | Abdominal pain 10 |
10 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Myalgia 10 |
10 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Oropharyngeal pain 10 |
10 |
| Reproductive system and breast disorders | E. not currently recognised | Amenorrhoea 9 |
9 |
| General disorders and administration site conditions | E. not currently recognised | Chest discomfort 9 |
9 |
| Vascular disorders | E. not currently recognised | Peripheral coldness 9 |
9 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Alopecia 8 |
8 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Cough 8 |
8 |
| Metabolism and nutrition disorders | E. not currently recognised | Decreased appetite 8 |
8 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Epistaxis 8 |
8 |
| General disorders and administration site conditions | E. not currently recognised | Fatigue 8 |
8 |
| General disorders and administration site conditions | E. not currently recognised | Influenza like illness 8 |
8 |
| Eye disorders | E. not currently recognised | Vision blurred 8 |
8 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Asthma 7 |
7 |
| Gastrointestinal disorders | E. not currently recognised | Diarrhoea 7 |
7 |
| General disorders and administration site conditions | E. not currently recognised | Feeling cold 7 |
7 |
| Nervous system disorders | E. not currently recognised | Hypoaesthesia 7 |
7 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Hypoaesthesia facial 7 |
7 |
| Eye disorders | E. not currently recognised | Photophobia 7 |
7 |
| Nervous system disorders | E. not currently recognised | Syncope 7 |
7 |
| Reproductive system and breast disorders | E. not currently recognised | Vaginal haemorrhage 7 |
7 |
| Infections and infestations | E. not currently recognised | Viral infection 7 |
7 |
| Eye disorders | E. not currently recognised | Vision blurred 7 |
7 |
| Gastrointestinal disorders | E. not currently recognised | Abdominal pain 6 |
6 |
| Nervous system disorders | E. not currently recognised | Dysarthria 6 |
6 |
| Ear and labyrinth disorders | E. not currently recognised | Ear pain 6 |
6 |
| Nervous system disorders | E. not currently recognised | Epilepsy 6 |
6 |
| Psychiatric disorders | E. not currently recognised | Hallucination 6 |
6 |
| Psychiatric disorders | E. not currently recognised | Insomnia 6 |
6 |
| Infections and infestations | E. not currently recognised | Lower respiratory tract infection 6 |
6 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Musculoskeletal stiffness 6 |
6 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Neck pain 6 |
6 |
| Cardiac disorders | E. not currently recognised | Palpitations 6 |
6 |
| Nervous system disorders | E. not currently recognised | Paraesthesia 6 |
6 |
| Infections and infestations | E. not currently recognised | Post viral fatigue syndrome 6 |
6 |
| Nervous system disorders | E. not currently recognised | Sensory disturbance 6 |
6 |
| Eye disorders | E. not currently recognised | Visual impairment 6 |
6 |
| General disorders and administration site conditions | E. not currently recognised | Abasia 5 |
5 |
| Nervous system disorders | E. not currently recognised | Dyskinesia 5 |
5 |
| Nervous system disorders | E. not currently recognised | Dysstasia 5 |
5 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Eczema 5 |
5 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Erythema multiforme 5 |
5 |
| Nervous system disorders | E. not currently recognised | Facial palsy 5 |
5 |
| Nervous system disorders | E. not currently recognised | Grand mal convulsion 5 |
5 |
| Reproductive system and breast disorders | E. not currently recognised | Menstruation irregular 5 |
5 |
| General disorders and administration site conditions | E. not currently recognised | Oedema peripheral 5 |
5 |
| Vascular disorders | E. not currently recognised | Pallor 5 |
5 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Sensation of heaviness 5 |
5 |
| Investigations | E. not currently recognised | Weight decreased 5 |
5 |
| Psychiatric disorders | E. not currently recognised | Anxiety 4 |
4 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Arthralgia 4 |
4 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Blister 4 |
4 |
| Investigations | E. not currently recognised | Blood glucose increased 4 |
4 |
| General disorders and administration site conditions | E. not currently recognised | Chills 4 |
4 |
| General disorders and administration site conditions | E. not currently recognised | Chronic fatigue syndrome 4 |
4 |
| General disorders and administration site conditions | E. not currently recognised | Condition aggravated 4 |
4 |
| Psychiatric disorders | E. not currently recognised | Confusional state 4 |
4 |
| Injury, poisoning and procedural complications | E. not currently recognised | Contusion 4 |
4 |
| Cardiac disorders | E. not currently recognised | Cyanosis 4 |
4 |
| Reproductive system and breast disorders | E. not currently recognised | Dysmenorrhoea 4 |
4 |
| Nervous system disorders | E. not currently recognised | Encephalitis 4 |
4 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Erythema 4 |
4 |
| General disorders and administration site conditions | E. not currently recognised | Feeling hot 4 |
4 |
| Nervous system disorders | E. not currently recognised | Guillain-barre syndrome 4 |
4 |
| Vascular disorders | E. not currently recognised | Hypotension 4 |
4 |
| Nervous system disorders | E. not currently recognised | Lethargy 4 |
4 |
| Reproductive system and breast disorders | E. not currently recognised | Menorrhagia 4 |
4 |
| Infections and infestations | E. not currently recognised | Nasopharyngitis 4 |
4 |
| Gastrointestinal disorders | E. not currently recognised | Nausea 4 |
4 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Rash 4 |
4 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Rash 4 |
4 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Skin discolouration 4 |
4 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Wheezing 4 |
4 |
| Surgical and medical procedures | E. not currently recognised | Abortion induced 3 |
3 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Alopecia 3 |
3 |
| Nervous system disorders | E. not currently recognised | Aphonia 3 |
3 |
| Nervous system disorders | E. not currently recognised | Convulsion 3 |
3 |
| Psychiatric disorders | E. not currently recognised | Disorientation 3 |
3 |
| Ear and labyrinth disorders | E. not currently recognised | Ear pain 3 |
3 |
| Nervous system disorders | E. not currently recognised | Epilepsy 3 |
3 |
| General disorders and administration site conditions | E. not currently recognised | Feeling abnormal 3 |
3 |
| Nervous system disorders | E. not currently recognised | Head discomfort 3 |
3 |
| Nervous system disorders | E. not currently recognised | Hemiparesis 3 |
3 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Hyperhidrosis 3 |
3 |
| Infections and infestations | E. not currently recognised | Infectious mononucleosis 3 |
3 |
| Pregnancy, puerperium and perinatal conditions | E. not currently recognised | Live birth 3 |
3 |
| Reproductive system and breast disorders | E. not currently recognised | Menstruation delayed 3 |
3 |
| Gastrointestinal disorders | E. not currently recognised | Mouth ulceration 3 |
3 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Muscle twitching 3 |
3 |
| Eye disorders | E. not currently recognised | Mydriasis 3 |
3 |
| Vascular disorders | E. not currently recognised | Peripheral coldness 3 |
3 |
| Pregnancy, puerperium and perinatal conditions | E. not currently recognised | Premature baby 3 |
3 |
| General disorders and administration site conditions | E. not currently recognised | Pyrexia 3 |
3 |
| Nervous system disorders | E. not currently recognised | Sensory loss 3 |
3 |
| Psychiatric disorders | E. not currently recognised | Tearfulness 3 |
3 |
| Nervous system disorders | E. not currently recognised | Tremor 3 |
3 |
| Nervous system disorders | E. not currently recognised | Unresponsive to stimuli 3 |
3 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Urticaria 3 |
3 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Urticaria chronic 3 |
3 |
| Nervous system disorders | E. not currently recognised | Visual field defect 3 |
3 |
| General disorders and administration site conditions | E. not currently recognised | Abasia 2 |
2 |
| Gastrointestinal disorders | E. not currently recognised | Abdominal pain upper 2 |
2 |
| Psychiatric disorders | E. not currently recognised | Abnormal behaviour 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Alopecia areata 2 |
2 |
| Reproductive system and breast disorders | E. not currently recognised | Amenorrhoea 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Angioedema 2 |
2 |
| Nervous system disorders | E. not currently recognised | Balance disorder 2 |
2 |
| Investigations | E. not currently recognised | Body temperature increased 2 |
2 |
| Vascular disorders | E. not currently recognised | Circulatory collapse 2 |
2 |
| Nervous system disorders | E. not currently recognised | Complex regional pain syndrome 2 |
2 |
| Nervous system disorders | E. not currently recognised | Complex regional pain syndrome 2 |
2 |
| Psychiatric disorders | E. not currently recognised | Confusional state 2 |
2 |
| Nervous system disorders | E. not currently recognised | Crying 2 |
2 |
| Metabolism and nutrition disorders | E. not currently recognised | Dehydration 2 |
2 |
| Psychiatric disorders | E. not currently recognised | Depressed mood 2 |
2 |
| Nervous system disorders | E. not currently recognised | Diplegia 2 |
2 |
| Eye disorders | E. not currently recognised | Diplopia 2 |
2 |
| Nervous system disorders | E. not currently recognised | Disturbance in attention 2 |
2 |
| Nervous system disorders | E. not currently recognised | Dizziness postural 2 |
2 |
| Nervous system disorders | E. not currently recognised | Drooling 2 |
2 |
| Injury, poisoning and procedural complications | E. not currently recognised | Drug exposure before pregnancy 2 |
2 |
| Nervous system disorders | E. not currently recognised | Dysgeusia 2 |
2 |
| Psychiatric disorders | E. not currently recognised | Emotional disorder 2 |
2 |
| Eye disorders | E. not currently recognised | Eye pain 2 |
2 |
| Nervous system disorders | E. not currently recognised | Facial paresis 2 |
2 |
| General disorders and administration site conditions | E. not currently recognised | Feeling cold 2 |
2 |
| General disorders and administration site conditions | E. not currently recognised | Gait disturbance 2 |
2 |
| General disorders and administration site conditions | E. not currently recognised | Gait disturbance 2 |
2 |
| Nervous system disorders | E. not currently recognised | Grand mal convulsion 2 |
2 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Groin pain 2 |
2 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Haemoptysis 2 |
2 |
| Vascular disorders | E. not currently recognised | Haemorrhage 2 |
2 |
| Infections and infestations | E. not currently recognised | Herpes zoster 2 |
2 |
| Infections and infestations | E. not currently recognised | Hordeolum 2 |
2 |
| Vascular disorders | E. not currently recognised | Hot flush 2 |
2 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Hyperventilation 2 |
2 |
| Nervous system disorders | E. not currently recognised | Hypokinesia 2 |
2 |
| Infections and infestations | E. not currently recognised | Influenza 2 |
2 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Joint swelling 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Livedo reticularis 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Livedo reticularis 2 |
2 |
| General disorders and administration site conditions | E. not currently recognised | Local swelling 2 |
2 |
| Nervous system disorders | E. not currently recognised | Loss of consciousness 2 |
2 |
| General disorders and administration site conditions | E. not currently recognised | Malaise 2 |
2 |
| Reproductive system and breast disorders | E. not currently recognised | Menstrual disorder 2 |
2 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Mobility decreased 2 |
2 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Muscle spasms 2 |
2 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Muscular weakness 2 |
2 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Musculoskeletal pain 2 |
2 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Musculoskeletal stiffness 2 |
2 |
| Nervous system disorders | E. not currently recognised | Optic neuritis 2 |
2 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Pain in extremity 2 |
2 |
| Vascular disorders | E. not currently recognised | Pallor 2 |
2 |
| Gastrointestinal disorders | E. not currently recognised | Paraesthesia oral 2 |
2 |
| Nervous system disorders | E. not currently recognised | Petit mal epilepsy 2 |
2 |
| Infections and infestations | E. not currently recognised | Pharyngitis 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Photosensitivity reaction 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Photosensitivity reaction 2 |
2 |
| Congenital, familial and genetic disorders | E. not currently recognised | Pilonidal cyst congenital 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Purpura 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Rash generalised 2 |
2 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Rheumatoid arthritis 2 |
2 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Rhinorrhoea 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Skin exfoliation 2 |
2 |
| Psychiatric disorders | E. not currently recognised | Sleep disorder 2 |
2 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Swelling face 2 |
2 |
| Cardiac disorders | E. not currently recognised | Tachycardia 2 |
2 |
| Renal and urinary disorders | E. not currently recognised | Urinary incontinence 2 |
2 |
| Renal and urinary disorders | E. not currently recognised | Urinary retention 2 |
2 |
| Infections and infestations | E. not currently recognised | Urinary tract infection 2 |
2 |
| Ear and labyrinth disorders | E. not currently recognised | Vertigo 2 |
2 |
| Eye disorders | E. not currently recognised | Visual impairment 2 |
2 |
| Reproductive system and breast disorders | E. not currently recognised | Vulval ulceration 2 |
2 |
| Investigations | E. not currently recognised | Weight increased 2 |
2 |
| Gastrointestinal disorders | E. not currently recognised | Abdominal discomfort 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Abdominal discomfort 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Abdominal pain lower 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Abdominal pain upper 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Abnormal faeces 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Abnormal sleep-related event 1 |
1 |
| Infections and infestations | E. not currently recognised | Abscess 1 |
1 |
| Infections and infestations | E. not currently recognised | Acarodermatitis 1 |
1 |
| Eye disorders | E. not currently recognised | Accommodation disorder 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Acne 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Acne 1 |
1 |
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | E. not currently recognised | Acute myeloid leukaemia 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Acute psychosis 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Acute respiratory failure 1 |
1 |
| Endocrine disorders | E. not currently recognised | Adrenocortical insufficiency acute 1 |
1 |
| Endocrine disorders | E. not currently recognised | Adrenocortical insufficiency acute 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Aggression 1 |
1 |
| Investigations | E. not currently recognised | Alanine aminotransferase increased 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Alopecia areata 1 |
1 |
| Blood and lymphatic system disorders | E. not currently recognised | Anaemia 1 |
1 |
| Infections and infestations | E. not currently recognised | Anogenital warts 1 |
1 |
| Nervous system disorders | E. not currently recognised | Aphasia 1 |
1 |
| Blood and lymphatic system disorders | E. not currently recognised | Aplastic anaemia 1 |
1 |
| Infections and infestations | E. not currently recognised | Application site pustules 1 |
1 |
| Nervous system disorders | E. not currently recognised | Areflexia 1 |
1 |
| Congenital, familial and genetic disorders | E. not currently recognised | Arteriovenous malformation 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Arthritis 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Arthritis reactive 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Arthropathy 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Asthenia 1 |
1 |
| Nervous system disorders | E. not currently recognised | Ataxia 1 |
1 |
| Injury, poisoning and procedural complications | E. not currently recognised | Axillary nerve injury 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Axillary pain 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Back pain 1 |
1 |
| Nervous system disorders | E. not currently recognised | Balance disorder 1 |
1 |
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | E. not currently recognised | Benign hydatidiform mole 1 |
1 |
| Infections and infestations | E. not currently recognised | Beta haemolytic streptococcal infection 1 |
1 |
| Eye disorders | E. not currently recognised | Blindness unilateral 1 |
1 |
| Investigations | E. not currently recognised | Blood cortisol decreased 1 |
1 |
| Investigations | E. not currently recognised | Blood pressure decreased 1 |
1 |
| Investigations | E. not currently recognised | Blood pressure increased 1 |
1 |
| Investigations | E. not currently recognised | Body temperature increased 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Bone pain 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Breast pain 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Breast swelling 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Breast tenderness 1 |
1 |
| Infections and infestations | E. not currently recognised | Bronchitis 1 |
1 |
| Nervous system disorders | E. not currently recognised | Burning sensation 1 |
1 |
| Cardiac disorders | E. not currently recognised | Cardiac arrest 1 |
1 |
| Investigations | E. not currently recognised | Cell marker increased 1 |
1 |
| Congenital, familial and genetic disorders | E. not currently recognised | Cerebral palsy 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Cervix inflammation 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Chest discomfort 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Chest pain 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Chills 1 |
1 |
| Nervous system disorders | E. not currently recognised | Chorea 1 |
1 |
| Congenital, familial and genetic disorders | E. not currently recognised | Cleft palate 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Cold sweat 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Colitis 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Colitis ulcerative 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Condition aggravated 1 |
1 |
| Eye disorders | E. not currently recognised | Conjunctival hyperaemia 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Constipation 1 |
1 |
| Nervous system disorders | E. not currently recognised | Coordination abnormal 1 |
1 |
| Investigations | E. not currently recognised | Csf cell count increased 1 |
1 |
| Eye disorders | E. not currently recognised | Dark circles under eyes 1 |
1 |
| Ear and labyrinth disorders | E. not currently recognised | Deafness 1 |
1 |
| Ear and labyrinth disorders | E. not currently recognised | Deafness bilateral 1 |
1 |
| Metabolism and nutrition disorders | E. not currently recognised | Decreased appetite 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Decreased interest 1 |
1 |
| Vascular disorders | E. not currently recognised | Deep vein thrombosis 1 |
1 |
| Nervous system disorders | E. not currently recognised | Depressed level of consciousness 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Depression 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Depression 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Depressive symptom 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Dermatitis allergic 1 |
1 |
| Metabolism and nutrition disorders | E. not currently recognised | Diabetes mellitus inadequate control 1 |
1 |
| Metabolism and nutrition disorders | E. not currently recognised | Diabetes mellitus inadequate control 1 |
1 |
| Metabolism and nutrition disorders | E. not currently recognised | Diabetic ketoacidosis 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Diarrhoea 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Diarrhoea haemorrhagic 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Discomfort 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Dissociation 1 |
1 |
| Nervous system disorders | E. not currently recognised | Dizziness postural 1 |
1 |
| Eye disorders | E. not currently recognised | Dry eye 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Dry skin 1 |
1 |
| Nervous system disorders | E. not currently recognised | Dysgeusia 1 |
1 |
| Nervous system disorders | E. not currently recognised | Dyskinesia 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Dysphemia 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Dyspnoea 1 |
1 |
| Ear and labyrinth disorders | E. not currently recognised | Ear discomfort 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Eating disorder 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Eczema vesicular 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Emotional distress 1 |
1 |
| Nervous system disorders | E. not currently recognised | Encephalitis 1 |
1 |
| Blood and lymphatic system disorders | E. not currently recognised | Eosinophilia 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Erythema 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Erythema multiforme 1 |
1 |
| Eye disorders | E. not currently recognised | Excessive eye blinking 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Exercise tolerance decreased 1 |
1 |
| Eye disorders | E. not currently recognised | Eye discharge 1 |
1 |
| Eye disorders | E. not currently recognised | Eye disorder 1 |
1 |
| Eye disorders | E. not currently recognised | Eye pain 1 |
1 |
| Eye disorders | E. not currently recognised | Eye swelling 1 |
1 |
| Eye disorders | E. not currently recognised | Eyelid oedema 1 |
1 |
| Nervous system disorders | E. not currently recognised | Facial palsy 1 |
1 |
| Injury, poisoning and procedural complications | E. not currently recognised | Fall 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Fear 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Feeling abnormal 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Flank pain 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Flatulence 1 |
1 |
| Vascular disorders | E. not currently recognised | Flushing 1 |
1 |
| Infections and infestations | E. not currently recognised | Folliculitis 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Frequent bowel movements 1 |
1 |
| Infections and infestations | E. not currently recognised | Furuncle 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Gastrointestinal disorder 1 |
1 |
| Eye disorders | E. not currently recognised | Gaze palsy 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Gingival disorder 1 |
1 |
| Nervous system disorders | E. not currently recognised | Guillain-barre syndrome 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Guttate psoriasis 1 |
1 |
| Blood and lymphatic system disorders | E. not currently recognised | Haemolytic uraemic syndrome 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Hallucination, auditory 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Hallucination, visual 1 |
1 |
| Congenital, familial and genetic disorders | E. not currently recognised | Heart disease congenital 1 |
1 |
| Investigations | E. not currently recognised | Heart rate decreased 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Henoch-schonlein purpura 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Henoch-schonlein purpura 1 |
1 |
| Infections and infestations | E. not currently recognised | Hepatitis viral 1 |
1 |
| Infections and infestations | E. not currently recognised | Herpes zoster 1 |
1 |
| Ear and labyrinth disorders | E. not currently recognised | Hyperacusis 1 |
1 |
| Metabolism and nutrition disorders | E. not currently recognised | Hyperglycaemia 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Hyperhidrosis 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Hyperpyrexia 1 |
1 |
| Immune system disorders | E. not currently recognised | Hypersensitivity 1 |
1 |
| Nervous system disorders | E. not currently recognised | Hypertonia 1 |
1 |
| Ear and labyrinth disorders | E. not currently recognised | Hypoacusis 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Hypoaesthesia facial 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Hypoaesthesia oral 1 |
1 |
| Metabolism and nutrition disorders | E. not currently recognised | Hypoglycaemia 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Hypomania 1 |
1 |
| Congenital, familial and genetic disorders | E. not currently recognised | Hypospadias 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Hypoventilation 1 |
1 |
| Injury, poisoning and procedural complications | E. not currently recognised | Inappropriate schedule of drug administration 1 |
1 |
| Injury, poisoning and procedural complications | E. not currently recognised | Incorrect dose administered 1 |
1 |
| Metabolism and nutrition disorders | E. not currently recognised | Increased appetite 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Increased upper airway secretion 1 |
1 |
| Infections and infestations | E. not currently recognised | Infection 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Inflammation 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Injection site erythema 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Injection site injury 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Injection site swelling 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Insomnia 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Intestinal functional disorder 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Irritable bowel syndrome 1 |
1 |
| Nervous system disorders | E. not currently recognised | Ivth nerve paralysis 1 |
1 |
| Hepatobiliary disorders | E. not currently recognised | Jaundice 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Joint stiffness 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Joint stiffness 1 |
1 |
| Infections and infestations | E. not currently recognised | Kidney infection 1 |
1 |
| Infections and infestations | E. not currently recognised | Labyrinthitis 1 |
1 |
| Infections and infestations | E. not currently recognised | Laryngitis 1 |
1 |
| Congenital, familial and genetic disorders | E. not currently recognised | Limb malformation 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Lip blister 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Lip swelling 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Local swelling 1 |
1 |
| Nervous system disorders | E. not currently recognised | Meningism 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Menorrhagia 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Menstrual disorder 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Menstruation delayed 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Menstruation irregular 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Metrorrhagia 1 |
1 |
| Nervous system disorders | E. not currently recognised | Migraine 1 |
1 |
| Nervous system disorders | E. not currently recognised | Migraine with aura 1 |
1 |
| Infections and infestations | E. not currently recognised | Molluscum contagiosum 1 |
1 |
| Nervous system disorders | E. not currently recognised | Monoplegia 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Muscle rigidity 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Muscle twitching 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Musculoskeletal chest pain 1 |
1 |
| Nervous system disorders | E. not currently recognised | Myoclonic epilepsy 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Nasal congestion 1 |
1 |
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | E. not currently recognised | Neoplasm malignant 1 |
1 |
| Nervous system disorders | E. not currently recognised | Neuritis 1 |
1 |
| Renal and urinary disorders | E. not currently recognised | Neurogenic bladder 1 |
1 |
| Blood and lymphatic system disorders | E. not currently recognised | Neutropenia 1 |
1 |
| Investigations | E. not currently recognised | Neutrophil count decreased 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Oedema peripheral 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Oropharyngeal blistering 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Oropharyngeal pain 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Osteitis 1 |
1 |
| Infections and infestations | E. not currently recognised | Otitis media 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Pain 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Palindromic rheumatism 1 |
1 |
| Blood and lymphatic system disorders | E. not currently recognised | Pancytopenia 1 |
1 |
| Nervous system disorders | E. not currently recognised | Paralysis 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Paranoia 1 |
1 |
| Investigations | E. not currently recognised | Peak expiratory flow rate decreased 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Petechiae 1 |
1 |
| Eye disorders | E. not currently recognised | Photopsia 1 |
1 |
| Investigations | E. not currently recognised | Platelet count decreased 1 |
1 |
| Infections and infestations | E. not currently recognised | Pneumonia viral 1 |
1 |
| Renal and urinary disorders | E. not currently recognised | Pollakiuria 1 |
1 |
| Pregnancy, puerperium and perinatal conditions | E. not currently recognised | Pregnancy with injectable contraceptive 1 |
1 |
| Nervous system disorders | E. not currently recognised | Presyncope 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Productive cough 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Psoriasis 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Psychiatric symptom 1 |
1 |
| Nervous system disorders | E. not currently recognised | Psychomotor hyperactivity 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Psychotic disorder 1 |
1 |
| Investigations | E. not currently recognised | Radial pulse 1 |
1 |
| Nervous system disorders | E. not currently recognised | Radiculitis brachial 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Rash erythematous 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Rash maculo-papular 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Rash vesicular 1 |
1 |
| Renal and urinary disorders | E. not currently recognised | Renal failure 1 |
1 |
| Investigations | E. not currently recognised | Respiratory rate increased 1 |
1 |
| Infections and infestations | E. not currently recognised | Respiratory syncytial virus infection 1 |
1 |
| Infections and infestations | E. not currently recognised | Respiratory tract infection 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Screaming 1 |
1 |
| Nervous system disorders | E. not currently recognised | Sedation 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Sensation of foreign body 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Sensation of pressure 1 |
1 |
| Nervous system disorders | E. not currently recognised | Sensory loss 1 |
1 |
| Infections and infestations | E. not currently recognised | Sepsis 1 |
1 |
| Infections and infestations | E. not currently recognised | Severe acute respiratory syndrome 1 |
1 |
| Cardiac disorders | E. not currently recognised | Sinus tachycardia 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Skin burning sensation 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Skin disorder 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Skin hypertrophy 1 |
1 |
| Infections and infestations | E. not currently recognised | Skin infection 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Skin irritation 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Skin lesion 1 |
1 |
| Psychiatric disorders | E. not currently recognised | Somatisation disorder 1 |
1 |
| Nervous system disorders | E. not currently recognised | Somnolence 1 |
1 |
| Nervous system disorders | E. not currently recognised | Speech disorder 1 |
1 |
| Infections and infestations | E. not currently recognised | Staphylococcal infection 1 |
1 |
| Nervous system disorders | E. not currently recognised | Status epilepticus 1 |
1 |
| Infections and infestations | E. not currently recognised | Streptococcal sepsis 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Swelling 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Swollen tongue 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Systemic inflammatory response syndrome 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Temperature intolerance 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Tenderness 1 |
1 |
| General disorders and administration site conditions | E. not currently recognised | Thirst 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Throat tightness 1 |
1 |
| Ear and labyrinth disorders | E. not currently recognised | Tinnitus 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Trichorrhexis 1 |
1 |
| Metabolism and nutrition disorders | E. not currently recognised | Type 1 diabetes mellitus 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Upper airway obstruction 1 |
1 |
| Infections and infestations | E. not currently recognised | Upper respiratory tract infection 1 |
1 |
| Renal and urinary disorders | E. not currently recognised | Urinary retention 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Urticaria 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Vaginal discharge 1 |
1 |
| Reproductive system and breast disorders | E. not currently recognised | Vaginal lesion 1 |
1 |
| Infections and infestations | E. not currently recognised | Varicella 1 |
1 |
| Infections and infestations | E. not currently recognised | Viraemia 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Vitiligo 1 |
1 |
| Eye disorders | E. not currently recognised | Vitreous floaters 1 |
1 |
| Gastrointestinal disorders | E. not currently recognised | Vomiting 1 |
1 |
| Musculoskeletal and connective tissue disorders | E. not currently recognised | Weight bearing difficulty 1 |
1 |
| Investigations | E. not currently recognised | Weight decreased 1 |
1 |
| Respiratory, thoracic and mediastinal disorders | E. not currently recognised | Wheezing 1 |
1 |
| Injury, poisoning and procedural complications | E. not currently recognised | Wrong technique in drug usage process 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Yellow skin 1 |
1 |
| Skin and subcutaneous tissue disorders | E. not currently recognised | Stevens-johnson syndrome 1 |
Filed under: ADHD, Aspergers, autism, Child Health Safety, MMR, vaccination, vaccine, vaccine court, Vaccine Damage, Vaccines | Tagged: ADHD, Anti-vaccine Safety, Aspergers, autism, Cervarix, Gardasil, government, Health, HPV, HPV vaccine, medicine, mercury, MMR, politics, science, thimerosal, thiomersal, vaccination, vaccine, vaccine court, Vaccine Damage, Vaccines | 6 Comments »
____________________Child Health Safety_________________ 